✦ LIBER ✦

Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99)

✍ Scribed by G. Fechner; R. Siener; M. Reimann; L. Kobalz; P. Albers; Members Of The German Association Of Urologic Oncology (Auo) Bladder Cancer Study Group

Book ID: 111307789
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 91 KB
Volume: 60
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2005.00663.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab

Phase II Trial of Weekly Paclitaxel and

Phase II Trial of Weekly Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Transitional Cell Cancer

✍ Manfred Johannsen; Markus Sachs; Jan Roigas; Axel Hinke; Andrea Staack; Stefan A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Phase 1 trial of lipoplatin and gemcitab

Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma

✍ Marios E. Froudarakis; Athanasia Pataka; Periklis Pappas; Stavros Anevlavis; Eva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Prognostic Factors in Second-Line Treatm

Prognostic Factors in Second-Line Treatment of Urothelial Cancers With Gemcitabine and Paclitaxel (German Association of Urological Oncology Trial AB20/99)

✍ Günter Niegisch; Rolf Fimmers; Roswitha Siener; Su-In Park; Peter Albers 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Methotrexate-paclitaxel-epirubicin-carbo

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

✍ Amal Halim; Niveen Abotouk 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Second-line chemotherapy with weekly pac

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

✍ Vincenzo Dongiovanni; Lucio Buffoni; Alfredo Berruti; Diego Dongiovanni; Raffael 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 198 KB